Mechanisms of Thrombus Formation
The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
Hemostasis is the process that maintains the integrity of a closed, high-pressure circulatory system after vascular damage. Vessel-wall injury and the extravasation of blood from the circulation rapidly initiate events in the vessel wall and in blood that seal the breach. Circulating platelets are recruited to the site of injury, where they become a major component of the developing thrombus; blood coagulation, initiated by tissue factor, culminates in the generation of thrombin and fibrin. These events occur concomitantly (Figure 1A; also see Video, available with the full text of this article at www.nejm.org), and under normal conditions, regulatory mechanisms contain . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These endothelial mediators subserve functions as varied as local flow distribution,91 immune surveillance (in concert with perivascular cells),92 and hemostatic balance.93”
In the citing paper
“Fibrinolytic therapy helps in dissolving fibrins in occluded vessels and improving the tumor vasculature [32,33,34,35,36].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [35]
In the citing paper
“enhanced platelet reactivity and acute thrombotic occlusion of vessels are the proximate cause of myocardial infarction, stroke and the majority of deaths in patients with CVD36.”
From Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential (2018) · cites this paper as [36]
Citations
Cites
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., & Chaudhuri, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9265 · Cited by 5,074
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Vu, T.-K. H., Hung, D. T., Wheaton, V. I., & Coughlin, S. R. (1991) · Cell · doi:10.1016/0092-8674(91)90261-v · Cited by 2,970
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier
MACFARLANE, R. G. (1964) · Nature · doi:10.1038/202498a0 · Cited by 1,119
Waterfall Sequence for Intrinsic Blood Clotting
Davie, E. W., & Ratnoff, O. D. (1964) · Science · doi:10.1126/science.145.3638.1310 · Cited by 1,113
The Roles of Protein C and Thrombomodulin in the Regulation of Blood Coagulation
Esmon, C. T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83649-3 · Cited by 1,046
Blood-borne tissue factor: Another view of thrombosis
Giesen, P. L. A., Rauch, U., Bohrmann, B., Kling, D., Roqué, M., Fallon, J. T., Badimon, J. J., Himber, J., Riederer, M. A., & Nemerson, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2311 · Cited by 991
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Cotran, R. S., & Gimbrone, M. A. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.2.618 · Cited by 935
Research works printed but not linked: 4
- Semeraro N, 1983, Immunology, 50, 529
- Reinhardt C, 2008, J Clin Invest, 118, 1110
- Cho J, 2008, J Clin Invest, 118, 1123
- 1986, Lancet, 1, 397
Cited by
Items 501–600 of 1,000
Feeling the Force: Measurements of Platelet Contraction and Their Diagnostic Implications
Williams, E. K., Oshinowo, O. T., Ravindran, A., Lam, W. A., & Myers, D. R. (2018) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0038-1676315 · Cited by 39
Wei, X., Luo, M., Xie, Y., Yang, L., Li, H., Xu, L., & Liu, H. (2012) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-012-9894-2 · Cited by 40
An Updated Concept of Coagulation With Clinical Implications
Romney, G., & Glick, M. (2009) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2009.0227 · Cited by 39
Microneedle-mediated drug delivery for scar prevention and treatment.
Mbituyimana, B., Bukatuka, C. F., Qi, F., Ma, G., Shi, Z.-J., & Yang, G. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103801 · Cited by 34
Diverse origins of fibrinolytic enzymes: A comprehensive review
Hazare, C., Bhagwat, P. K., Singh, S., & Pillai, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e26668 · Cited by 43
“The aggregation of platelets, fibrin, and thrombin in the arteries causes arterial thrombosis, contributing to the emergence and spreading of atherosclerotic plaque, resulting in myocardial infarction [6,7].”
BackgroundGalli, M., Abbate, A., Bonaca, M. P., Crea, F., Forte, M., Frati, G., Gaudino, M. F. L., Gibson, C. M., Gorog, D. A., Mehran, R., et al. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01249-z · Cited by 52
“…event, such as type I myocardial infarction (MI), caused by atherosclerotic plaque destabilization (whether through rupture or erosion), pathological thrombus formation in the culprit coronary artery involves activation of platelets and the coagulation cascade, culminating in clot formation 12 .”
InfluentialAngerås, O., Hasvold, P., Thuresson, M., Deleskog, A., & ÖBraun, O. (2015) · Scandinavian Cardiovascular Journal · doi:10.3109/14017431.2015.1119304 · Cited by 38
Chang, C., Li, C., Yu, C.-C., Chen, Y., Chyntara, S., Chu, J. P., Chen, M., & Chang, S. (2018) · Surface and Coatings Technology · doi:10.1016/j.surfcoat.2018.03.040 · Cited by 38
Engineered platelets-based drug delivery platform for targeted thrombolysis
Wang, S., Wang, R., Meng, N., Lu, L., Wang, J., Zhou, J., Lu, J., Xu, Q., Xie, C., Zhan, C., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.01.004 · Cited by 38
Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism
Bal, L., Éderhy, S., Angelantonio, E. D., Toti, F., Zobairi, F., Dufaître, G., Meuleman, C., Mallat, Z., Boccara, F., Tedgui, A., et al. (2010) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2010.06.005 · Cited by 40
Purinergic control of inflammation and thrombosis: Role of P2X1 receptors
Oury, C., Lecut, C., Hego, A., Wéra, O., & Delierneux, C. (2014) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2014.11.008 · Cited by 38
“Under normal conditions, regulatory mechanisms restrain thrombus formation both temporally and spatially [1].”
BackgroundPersonalized medicine and antiplatelet therapy: ready for prime time?
Verstuyft, C., Simon, T., & Kim, R. B. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp295 · Cited by 38
“Consequently, binding of ADP to P2Y12 receptor not only amplifies the aggregation response but also increases granule secretion and platelet procoagulant activity.(30) Therefore ADP-mediated activation of P2Y12 represents a critical pathway that results in arterial thrombosis and the accompanying tissue anoxia and inf…”
BackgroundCurrent Strategies in Cardiovascular Biomaterial Functionalization
Schopka, S., Schmid, T. M., Schmid, Ç., & Lehle, K. (2010) · Materials · doi:10.3390/ma3010638 · Cited by 44
NF-κB signaling pathway as target for antiplatelet activity
Fuentes, E., Rojas, A., & Palomo, I. F. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.03.002 · Cited by 41
Current views of haemolytic streptococcal pathogenesis
Tan, L., Eccersley, L. R. J., & Sriskandan, S. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000047 · Cited by 37
Coagulation, platelet activation and thrombosis in xenotransplantation
Schmelzle, M., Esch, J. S. A., & Robson, S. C. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283373ccc · Cited by 39
Progressive postinjury thrombocytosis is associated with thromboembolic complications
Kashuk, J. L., Moore, E. E., Johnson, J. L., Biffl, W. L., Burlew, C. C., Barnett, C. C., & Sauaia, A. (2010) · Surgery · doi:10.1016/j.surg.2010.07.013 · Cited by 37
Akhmedov, A., Camici, G. G., Reiner, M. F., Bonetti, N. R., Costantino, S., Holy, E. W., Spescha, R. D., Stivala, S., Clerigué, A. S., Speer, T., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx015 · Cited by 40
“Indeed, after plaque rupture or erosion in culprit coronary arteries as it occurs in acute coronary syndromes (ACS),(2) local platelet adhesion and fibrin formation ensues eventually leading to distal embolism of thrombotic material and/or complete vascular occlusion at the site of vascular injury.(3) Similarly, in th…”
BackgroundAdvances of biological macromolecules hemostatic materials: A review
Zhang, M., Han, F., Duan, X., Zheng, D., Cui, Q., & Liao, W. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131772 · Cited by 37
Exploring Staphylococcus aureus pathways to disease for vaccine development
DeDent, A. C., Kim, H. K., Missiakas, D. M., & Schneewind, O. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0299-z · Cited by 41
“oxide and prostacyclin which prevent the aggregation of platelets [101].”
BackgroundEffects of shear-dependent viscosity and hematocrit on blood flow
Ameenuddin, M., Anand, M., & Massoudi, M. (2019) · Applied Mathematics and Computation · doi:10.1016/j.amc.2019.03.028 · Cited by 47
Chowdhury, M. R., Chowdhury, K. H., Hanif, N. B., Sayeed, M. A., Mouah, J., Mahmud, I., Kamal, A. T. M. M., Chy, M. N. U., & Adnan, M. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04895 · Cited by 36
“Thrombosis is a critical event caused by plaque generation in a blood vessel due to platelets, tissue factors and fi brin deposition [78].”
BackgroundO’Brien, P., & Mureebe, L. (2011) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248410395941 · Cited by 36
“Small amounts of thrombin are generated, leading to activation of Factors V and VIII, and subsequent amplification of thrombin production predominately through the prothrombinase and tenase complexes.(7) Factors Xa, Va, and prothrombin (II) form the prothrombinase complex on the platelet surface and, in the presence o…”
BackgroundLimitations of current therapies to prevent thrombosis: a need for novel strategies
Fabre, J., & Gurney, M. E. (2009) · Molecular BioSystems · doi:10.1039/b914375k · Cited by 36
Rojano, R. M., Mendez, S., & Nicoud, F. (2018) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-017-0994-3 · Cited by 36
Ntelis, K., Bogdanos, D. P., Dimitroulas, T., Sakkas, L. I., & Daoussis, D. (2019) · Current Rheumatology Reports · doi:10.1007/s11926-019-0815-z · Cited by 37
Bhardwaj, S., & Angayarkanni, J. (2014) · 3 Biotech · doi:10.1007/s13205-014-0209-x · Cited by 35
“In the physiological state, fibrin and platelets are utilized for clotting to prevent blood loss from injuries in a process called haemostasis (Furie and Furie 2008).”
BackgroundJi, P., Xu, Q., Li, J., Wang, Z., Mao, W., & Yan, P. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117564 · Cited by 40
Diehl, P., Schnabel, K., Weik, P., Zhou, Q., Bode, C., Moser, M., & Olivier, C. B. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-06-0508 · Cited by 35
“Coronary plaque rupture often leads to platelet activation and aggregation, thrombus formation with consecutive vessel occlusion and ischaemia of the downstream located tissue with consecutive myocardial infarction (MI) (2).”
BackgroundTamura, T., Sakaeda, T., Kadoyama, K., & Okuno, Y. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.4549 · Cited by 35
“Antiplatelets are the basis for prevention of arterial thrombosis, whereas anticoagulants are effective for venous thrombosis; however, recent molecular investigations suggest the interdependence of platelets and the coagulation system in both forms of thrombosis [2], and physicians often recommend their combinations…”
BackgroundSayari, N., Balti, R., Mansour, M. B., Amor, I. B., Graiet, I., Gargouri, J., & Bougatef, A. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.03.027 · Cited by 37
“coronary syndrome and pulmonary embolism [14].”
Blood Coagulation as an Intrinsic Pathway for Proinflammation: A Mini Review
Chu, A. J. (2010) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152810791292890 · Cited by 35
“, protein disulfide isomerase) [16, 18, 19], or advanced glycated end products under hyperglycemia.”
BackgroundInfluentialMujalli, A., Chicanne, G., Bertrand‐Michel, J., Viars, F., Stephens, L., Hawkins, P. T., Viaud, J., Gaits‐Iacovoni, F., Séverin, S., Gratacap, M., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.06.009 · Cited by 35
Chaudhry, S. A., Serrata, M., Tomczak, L., Higgins, S. J., Ryu, J. H., Laprise, D., Enjyoji, K., Bekendam, R. H., Kaushik, V. K., Flaumenhaft, R. C., et al. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14964 · Cited by 35
Clotting disorder in severe acute respiratory syndrome coronavirus 2
Pujhari, S. K., Paul, S., Ahluwalia, J., & Rasgon, J. L. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2177 · Cited by 36
“Thrombin is a serine protease that catalyses coagulation‐ related reactions and converts soluble fibrinogen into insoluble fibrin.(25)”
BackgroundPrecision Navigation of Venous Thrombosis Guided by Viscosity-Activatable Near-Infrared Fluorescence
Zhang, W., Li, M., Wang, X., Zhang, W., Wang, H., Li, P., & Tang, B. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c04395 · Cited by 36
Tokuda, H., Kuroyanagi, G., Tsujimoto, M., Enomoto, Y., Matsushima‐Nishiwaki, R., Onuma, T., Kojima, A., Doi, T., Tanabe, K., Akamatsu, S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128977 · Cited by 35
Extracellular Vesicles in Hematological Disorders
Aharon, A., Rebibo-Sabbah, A., Tzoran, I., & Levin, C. (2014) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10166 · Cited by 35
Epigenetic regulatory mechanism of macrophage polarization in diabetic wound healing (Review)
Song, J., Wu, Y., Chen, Y., Sun, X., & Zhang, Z. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13367 · Cited by 38
A randomized, double blind trial of prophylactic fibrinogen to reduce bleeding in cardiac surgery
Sadeghi, M., Atef‐Yekta, R., Azimaraghi, O., Marashi, S. M., Aghajani, Y., Ghadimi, F., Spahn, D. R., & Movafegh, A. (2013) · Brazilian Journal of Anesthesiology (English Edition) · doi:10.1016/j.bjane.2013.10.010 · Cited by 35
Perioperative Platelet Transfusions
Hess, A. S., Ramamoorthy, J., & Hess, J. R. (2021) · Anesthesiology · doi:10.1097/aln.0000000000003670 · Cited by 35
“Platelets provide both primary hemostasis through the formation of a platelet plug and secondary hemostasis by providing “rafts” of negatively charged surface phospholipids on which the amplification and propagation phases of plasma coagulation occur.(1) If lost or dysfunctional platelets need to be replaced quickly,…”
BackgroundKulkarni, P. P., Ekhlak, M., Singh, V., Kailashiya, V., Singh, N. K., & Dash, D. (2023) · The FASEB Journal · doi:10.1096/fj.202201321rr · Cited by 34
Pharmacogenetics of the Antiplatelet Effect of Aspirin
Würtz, M., Kristensen, S. D., Hvas, A., & Grove, E. L. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803251907 · Cited by 34
“Several substances such as adhesive proteins, clotting factors, growth factors and membrane glycoproteins are released to adjacent platelets from subpopulations of -granules [8;9], whereas ADP and calcium ions are released from the dense granules [10].”
BackgroundRegulation of Platelet Function by Orai, STIM and TRP
Berna‐Erro, A., Jardín, I., Smani, T., & Rosado, J. A. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-26974-0_8 · Cited by 34
Vps33b regulates Vwf‐positive vesicular trafficking in megakaryocytes
Dai, J., Lu, Y., Wang, C., Chen, X., Fan, X., Gu, H., Wu, X., Wang, K., Gartner, T. K., Zheng, J., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4762 · Cited by 37
“Introduction Platelets are small anucleate components of circulating blood that are derived from megakaryocytes and play essential roles in haemostasis and thrombosis [1-3].”
Oxidative stress: An essential factor in the process of arteriovenous fistula failure
Hu, K., Guo, Y., Li, Y., Lu, C., Cai, C., Zhou, S., Ke, Z., Li, Y., & Wang, W. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.984472 · Cited by 36
“This is commonly referred to as the three elements of Virchow (31).”
BackgroundClinical significance of circulating microparticles for venous thrombo - embolism in cancer patients
Ay, C., Pabinger, I., & Thaler, J. (2011) · Hämostaseologie · doi:10.5482/ha-1164 · Cited by 33
“MP-bound TF was also reported to be present in an encrypted form in the circulation that is not involved in blood coagulation but in cell signaling (29, 30).”
BackgroundAdvances in understanding the pathogenesis of chronic thromboembolic pulmonary hypertension
Lang, I. M. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08142.x · Cited by 33
“Thus, the traditional view of thrombosis as a plasmatic problem of clot formation (Furie & Furie, 2008) is replaced by the view that the core of thrombosis is the vascular repair process that it entails.”
BackgroundMicroparticles variability in fresh frozen plasma: preparation protocol and storage time effects.
Kriebardis, A. G., Antonelou, M. H., Georgatzakou, H. Τ., Tzounakas, V. L., Stamoulis, K. E., & Papassideri, I. S. (2016) · PubMed Central · doi:10.2450/2016.0179-15 · Cited by 33
Kaide, C. G., & Gulseth, M. P. (2019) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2019.10.011 · Cited by 39
Cardiac xenotransplantation: a promising way to treat advanced heart failure
Shu, S., Ren, J., & Song, J. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09989-x · Cited by 34
“tinuously within the blood, but it is balanced by anticoagulants, hence preventing the formation of thrombus [123].”
BackgroundThe discovery and development of rivaroxaban
Misselwitz, F., Berkowitz, S. D., & Perzborn, E. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.05971.x · Cited by 38
Maugeri, N., Baldini, M., Rovere, P. Q., Maseri, A., Sabbadini, M. G., & Manfredi, A. A. (2009) · Autoimmunity · doi:10.1080/08916930902832629 · Cited by 34
“Figure 1 shows that expression of P-selectin was correlated with that of TF by circulating leukocytes, further supporting a link between the two events [10,11].”
BackgroundInfluentialTanaka, K., Okigami, M., Toiyama, Y., MORIMOTO, Y., Matsushita, K., Kawamura, M., Hashimoto, K., Saigusa, S., Okugawa, Y., Inoue, Y., et al. (2012) · Oncology Reports · doi:10.3892/or.2012.1983 · Cited by 33
“The platelet aggregation has been considered the surrogate of endothelial damage or hyper coagulable condition (24,25).”
Gheldof, D. D., Haguet, H., Dogné, J., Bouvy, C., Graux, C., George, F., Sonet, A., Chatelain, C., Châtelain, B., & Mullier, F. (2017) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-016-1471-z · Cited by 33
“They can be captured in the developing thrombus and lead to thrombin generation by expression of procoagulant phospholipids (PL) and TF [10, 11].”
Neutrophils: Linking Inflammation to Thrombosis and Unlocking New Treatment Horizons
Li, H., Shan, W., Zhao, X., & Sun, W. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051965 · Cited by 32
“Two main mechanisms mediate vascular homeostasis and thrombosis, depending on vascular injury or vascular architecture [5].”
Yuan, Z., Li, Y., Sun, M., Yuan, M., Han, Z., Li, X., Liu, S., Sun, Y., Cao, J., & Fan, L. (2025) · Theranostics · doi:10.7150/thno.106991 · Cited by 35
“Thrombi are primarily composed of activated platelets and fibrin, typically resulting from vascular injury, a hypercoagulable state, and slow blood flow [116].”
Redox properties of the tissue factor Cys186–Cys209 disulfide bond
Liang, H., Brophy, T. M., & Hogg, P. J. (2011) · Biochemical Journal · doi:10.1042/bj20110718 · Cited by 32
Xu, Y., Yu, G., Nie, R., & Wu, Z. (2022) · Open Research (University of Surrey) · doi:10.1002/viw.20200183 · Cited by 34
Long-term outcomes of patients with normal fractional flow reserve and thin-cap fibroatheroma
Fabris, E., Berta, B., Hommels, T. M., Roleder, T., Hermanides, R. S., Rivero, F., von Birgelen, C., Escaned, J., Camaro, C., Kennedy, M., et al. (2023) · EuroIntervention · doi:10.4244/eij-d-22-00306 · Cited by 33
Membrane microparticles in VTE and cancer
Key, N. S., Chantrathammachart, P., Moody, P. W., & Chang, J.-Y. (2010) · Thrombosis Research · doi:10.1016/s0049-3848(10)70020-7 · Cited by 34
“It is now relatively well established that circulating TF-bearing MPs contribute to fibrin generation during thrombosis [42].”
BackgroundThiol pathways in the regulation of tissue factor prothrombotic activity
Versteeg, H. H., & Ruf, W. (2011) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32834981de · Cited by 32
Sadeghi, M., Atef‐Yekta, R., Azimaraghi, O., Marashi, S. M., Aghajani, Y., Ghadimi, F., Spahn, D. R., & Movafegh, A. (2014) · Brazilian Journal of Anesthesiology · doi:10.1016/j.bjan.2013.10.008 · Cited by 35
Zhang, L., & Sun, Y. P. (2014) · Langmuir · doi:10.1021/la404599s · Cited by 32
Humanized Mouse Model of Thrombosis Is Predictive of the Clinical Efficacy of Antiplatelet Agents
Magallon, J., Chen, J., Rabbani, L. E., Dangas, G., Yang, J., Bussel, J. B., & Diacovo, T. G. (2011) · Circulation · doi:10.1161/circulationaha.110.951970 · Cited by 32
Recent Advances in Immunothrombosis and Thromboinflammation
Kaiser, R. W. J., Gold, C., & Stark, K. (2025) · Thrombosis and Haemostasis · doi:10.1055/a-2523-1821 · Cited by 37
“The monocyte TF signaling complexes consist of factors (F) X, FVII, TF and TFPI, the endothelial protein C receptor (EPCR), integrins, and protease activated receptor (PAR) 1 and 2.”
Microparticles: new light shed on the understanding of venous thromboembolism
Zhou, L., Qi, X., Xu, M., Mao, Y., Liu, M., & Song, H. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.73 · Cited by 31
Levin, C., Koren, A., Rebibo-Sabbah, A., Koifman, N., Brenner, B., & Aharon, A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01214 · Cited by 31
“In healthy individuals, EV-TF activity remains undetectable, but in pathological states, TF-bearing EVs may activate the coagulation cascade and induce thrombotic events (Furie and Furie, 2008; Geddings and Mackman, 2013).”
BackgroundCao, W., Wei, W., Qiu, B., Liu, Y., Xie, S., Fang, Q., & Li, X. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.149187 · Cited by 32
Gaffo, A. (2013) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2012.12.005 · Cited by 31
Cancer-related venous thromboembolism
Diab, A. I. A. (2010) · Hematology/Oncology and Stem Cell Therapy · doi:10.5144/1658-3876.2010.191 · Cited by 31
Holy, E. W., Besler, C., Reiner, M. F., Camici, G. G., Manz, J., Beer, J. H., Lüscher, T. F., Landmesser, U., & Tanner, F. C. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-09-0775 · Cited by 32
“Thrombosis is the critical event in acute vascular syndromes such as myocardial infarction, acute limb ischaemia, and stroke (1).”
BackgroundThrombus composition in sudden cardiac death from acute myocardial infarction
Silvain, J., Collet, J., Guedeney, P., Varenne, O., Nagaswami, C., Maupain, C., Empana, J. P., Boulanger, C. M., Tafflet, M., Manzo‐Silberman, S., et al. (2017) · Resuscitation · doi:10.1016/j.resuscitation.2017.01.030 · Cited by 32
Shen, D., Yang, Y., Kong, X., Ma, N., Liu, X., Li, S., Jiao, Z., Qin, Z., Huang, M., & Li, J. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.02.032 · Cited by 31
Debaugnies, F., Azerad, M., Noubouossie, D. F., Rozen, L., Hemker, H. C., Corazza, F., Efira, A., & Demulder, A. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.09.002 · Cited by 31
“These MP can be captured in the developing thrombus and lead to thrombin generation (TG) which amplifies fibrin propagation [3,4].”
BackgroundContemporary tools for evaluation of hemostasis in neonates. Where are we and where are we headed?
Sokou, R., Parastatidou, S., Konstantinidi, A., Tsantes, A. G., Iacovidou, N. M., Piovani, D., Bonovas, S., & Tsantes, A. Ε. (2023) · Blood Reviews · doi:10.1016/j.blre.2023.101157 · Cited by 30
Rapid Blood Clot Removal via Remote Delamination and Magnetization of Clot Debris
Wang, Q., Wang, B., Chan, K. F., Song, X., Wang, Q., Ji, F., Su, L., Ip, B. Y. M., Ko, H., Chiu, P. W. Y., et al. (2025) · Advanced Science · doi:10.1002/advs.202415305 · Cited by 30
Olive Oil as a Functional Food: Nutritional and Health Benefits
Perona, J. S., & Botham, K. M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7777-8_18 · Cited by 44
Immobilization of Actively Thromboresistant Assemblies on Sterile Blood‐Contacting Surfaces
Qu, Z., Krishnamurthy, V., Haller, C. A., Dorr, B. M., Marzec, U. M., Hurst, S., Hinds, M. T., Hanson, S. R., Liu, D. R., & Chaikof, E. L. (2013) · Advanced Healthcare Materials · doi:10.1002/adhm.201300110 · Cited by 32
Hook, K. M., & Abrams, C. S. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00351.x · Cited by 30
Catalytic dysregulation of SHP2 leading to Noonan syndromes affects platelet signaling and functions
Bellio, M., Garcia, C., Édouard, T., Voisin, S., Neel, B. G., Cabou, C., Valet, P., Mori, J., Mazharian, A., Senis, Y. A., et al. (2019) · Blood · doi:10.1182/blood.2019001543 · Cited by 30
Function and activation state of platelets in vitro depend on apheresis modality
Macher, S., Sipurzynski, S., Rosskopf, K., Rohde, E., Griesbacher, A., Groselj‐Strele, A., Lanzer, G., & Schallmoser, K. (2010) · Vox Sanguinis · doi:10.1111/j.1423-0410.2010.01353.x · Cited by 30
Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy
Tautz, L., Senis, Y. A., Oury, C., & Rahmouni, S. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.03.075 · Cited by 30
Disease dynamics in patients with acute myeloid leukemia: New biomarkers
Tzoran, I., Rebibo-Sabbah, A., Brenner, B., & Aharon, A. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.07.004 · Cited by 30
“Furthermore, EVs bearing tissue factor (TF), the main initiator of the coagulation cascade, play a major role in the pathogenesis of the prothrombotic state observed in patients with malignancies [9–11].”
BackgroundLow molecular weight heparin for prevention of microvascular occlusion in digital replantation
Chen, Y., Chi, C., Chan, F. C., & Wen, Y. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009894.pub2 · Cited by 30
Parallel multiscale simulations of a brain aneurysm
Grinberg, L., Fedosov, D. A., & Karniadakis, G. E. (2012) · Journal of Computational Physics · doi:10.1016/j.jcp.2012.08.023 · Cited by 30
“Furie reviewed two independent pathways to thrombus formation [25].”
BackgroundNikolsky (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s13263 · Cited by 31
“The randomized, double-blind, double-dummy DISPERSE (Dose confIrmation Study assessing anti-Platelet Effects of AZD6140 versus clopidogRel in non-ST segment Elevation myocardial infarction)-2 trial further evaluated the safety, tolerability, and initial efficacy of either AZD6140 or clopidogrel added to aspirin in 990…”
InfluentialWang, X., Luo, Y., Masci, P. P., Crawford, R., & Xiao, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149775 · Cited by 30
“While platelet aggregation provides temporary closure of the defect, the initiation of a multistep coagulation reaction in a highly efficient manner ensures that it remains mechanically stable via generation of the glue-like fibrin within a growing fracture hematoma [44].”
BackgroundIndications and Risks of Fibrinogen in Surgery and Trauma
Spahn, G. H., Stein, P., & Spahn, D. R. (2015) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0035-1564841 · Cited by 30
Donovan, A. J., Kalkowski, J., Szymusiak, M., Wang, C., Smith, S. A., Klie, R. F., Morrissey, J. H., & Liu, Y. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.6b00577 · Cited by 31
Im, S. H., Jung, Y., Jang, Y., & Kim, S. H. (2016) · Biofabrication · doi:10.1088/1758-5090/8/4/045010 · Cited by 29
Filho, I. P. T., Torres, L. N., Valdez, C., Salgado, C. L., Cap, A. P., & Dubick, M. A. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13556 · Cited by 29
The current understanding of trauma-induced coagulopathy (TIC): a focused review on pathophysiology
Giordano, S., Spiezia, L., Campello, E., & Simioni, P. (2017) · Internal and Emergency Medicine · doi:10.1007/s11739-017-1674-0 · Cited by 29
Stretching single fibrin fibers hampers their lysis
Li, W., Lucioni, T., Li, R., Bonin, K., Cho, S. S., & Guthold, M. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.07.037 · Cited by 29
Preoperative Management of Arteriovenous Fistula (AVF) for Hemodialysis
Alfano, G., Fontana, F., Iannaccone, M., Noussan, P., & Cappelli, G. (2017) · The Journal of Vascular Access · doi:10.5301/jva.5000771 · Cited by 29
“In accordance with Virchow’s triad (111), decelerated blood flow due to central-vein occlusion is a risk factor for vascular thrombosis (112) potentially leading to AV access loss.”
BackgroundRecent advances in smart nanoplatforms for tumor non-interventional embolization therapy
Dong, H., Yang, D., Hu, Y., & Song, X. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01548-w · Cited by 31
“Thrombin‐based nanoparticles for tumor embolization therapy The blood clot formed by the coagulation of the flowing blood in the vascular cavity or the cardiac cavity is called a thrombus, which can block the vascular cavity, significantly reduce the blood flow, cause severe tissue ischemia, and result in serious dise…”
BackgroundWang, X., Hadi, M. K., Niu, J., Zhou, Q., & Ran, F. (2023) · Macromolecules · doi:10.1021/acs.macromol.2c02501 · Cited by 31
Yunoki, K., Naruko, T., Sugioka, K., Inaba, M., Itoh, A., Haze, K., Yoshiyama, M., & Ueda, M. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.17608 · Cited by 37
II. Bringing flow into haemostasis diagnostics
Schött, U., Johansson, P. I., & Mahajan, R. P. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet289 · Cited by 29
Deka, A., Reza, M. A., Hoque, K. M. F., Deka, K., Saha, S., & Doley, R. (2019) · Toxicon · doi:10.1016/j.toxicon.2019.03.025 · Cited by 29
Metadata
- Authors
- Furie, B., & Furie, B. C.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- ORCID
- Furie, Bruce
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-08-28
- Volume
- 359
- Issue
- 9
- Pages
- 938-949
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1983760732
- Cited by
- 1,926
- References
- 122
- Citations by year
- 2026: 75 · 2025: 119 · 2024: 114 · 2023: 121 · 2022: 110 · 2021: 117 · 2020: 103 · 2019: 96 · 2018: 93 · 2017: 109 · 2016: 108 · 2015: 122 · 2014: 101 · 2013: 119 · 2012: 106
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL087203)
- Topics
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- thrombus formation, hemostasis, platelet recruitment, coagulation, tissue factor, thrombin, fibrin, vascular injury, coagulation regulation
- MeSH terms
- Animals, Blood Coagulation, Blood Coagulation Disorders, Fibrinolytic Agents, Humans, Neoplasms, Thrombosis, Platelet Activation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.